P8A:SGX
Cordlife Group Ltd
0,12 SGD
0,00%
(0,00) 1D
12. okt., 09.49.20 GMT+8 · SGD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for P8A...
Markedsværdi
32,37 mio.
Gns. vol.
1,32 t
Volumen
0,00
Højeste i 52 uger
0,26 SGD
Laveste i 52 uger
0,10 SGD
Indtægt pr. aktie
-0,04 SGD
Aktier i omløb
267,53 mio.
Antal ansatte
111
Markedsværdi
32,37 mio.
Gns. vol.
1,32 t
Volumen
0,00
Højeste i 52 uger
0,26 SGD
Laveste i 52 uger
0,10 SGD
Indtægt pr. aktie
-0,04 SGD
Aktier i omløb
267,53 mio.
Antal ansatte
111
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 14 timer siden
Mike McGlone: Kobberfutures og S&P 500 når rekordhøj korrelation
The Daily News | Texas' Oldest Newspaper
·
for 7 minutter siden
FILE PHOTO: SK Hynix at the Nasdaq market in New York
The Globe and Mail
·
for 24 minutter siden
U.S. Analyst Updates: October 14th, 2026
TradingView
·
for 1 time siden
S&P 500 ends longest streak of calm since 2020 as AI trade sinks
Profil
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Om Cordlife Group Ltd
Administrerende direktørYiu Pang Fai
Ansatte111
Grundlagt2. maj 2001
Hovedsæde-
SektorHealth care provider
Websitecordlife.com